Desjardins Global Asset Management Inc. Teva Pharmaceutical Industries LTD Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 8,123 shares of TEVA stock, worth $140,365. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,123
Previous 7,053
15.17%
Holding current value
$140,365
Previous $71,000
18.31%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
546Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$755 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$667 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$598 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$516 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$498 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...